Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.

Haematologica

Volumn 92, Issue 1, 2007, Pages

  Steiner, M ^a   Matthes Martin, S ^a   Attarbaschi, A ^a   Lawitschka, A ^a   Minkov, M ^a   Mittheisz, E ^a   Fritsch, G ^a   Lion, T ^a   Zoubek, A ^a   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CANCER ANTIBODY; DRUG DERIVATIVE; ETOPOSIDE; FLUDARABINE; MELPHALAN; MONOCLONAL ANTIBODY; PREDNISONE; VIDARABINE; VINBLASTINE;

ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DRUG COMBINATION; FEMALE; GRAFT SURVIVAL; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LYMPHOCYTE TRANSFUSION; MULTIMODALITY CANCER THERAPY; REMISSION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ETOPOSIDE; FEMALE; GRAFT SURVIVAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; LYMPHOCYTE TRANSFUSION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MELPHALAN; PREDNISONE; REMISSION INDUCTION; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; VINBLASTINE;

EID: 38449089771     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.10993     Document Type: Article

References (0)